Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 134 (6) , 1699-1714
- https://doi.org/10.1053/j.gastro.2008.02.069
Abstract
No abstract availableKeywords
This publication has 226 references indexed in Scilit:
- Influence of Cannabis Use on Severity of Hepatitis C DiseaseClinical Gastroenterology and Hepatology, 2008
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosisJournal of Hepatology, 2006
- Identification of Two Gene Variants Associated With Risk of Advanced Fibrosis in Patients With Chronic Hepatitis CGastroenterology, 2006
- Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis CJournal of Hepatology, 2005
- The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsJournal of Hepatology, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic populationJournal of Hepatology, 1994
- Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitisJournal of Hepatology, 1992